April 19, 2010 - President Barak Obama signed a bill granting temporary relief through June 1, 2010, from looming cuts to Medicare reimbursement rates, however, Michael Graham, Ph.D., M.D., president of the Society of Nuclear Medicine (SNM), stresses a need for a long-term solution.

April 14, 2010 – The Mount Sinai Medical Center in New York has become the first facility in the United States to commercially use a new cardiac nuclear imaging system that drastically reduces imaging time and radiation exposure.

April 14, 2010 - When college football’s elite enter Radio City Music Hall April 22 for the 2010 National Football League (NFL) draft, it will be after much public analysis of their stats and accomplishments. Also important to a player’s prospect of being drafted is the outcome of diagnostic tests including X-rays, magnetic resonance imaging (MRI) and cardiac evaluations.

April 14, 2010 - There will be greater personal interaction, exchange, and networking among attendees and exhibitors, at the Society for Imaging Informatics in Medicine's (SIIM) 2010 Annual Meeting, June 3-6 in Minneapolis. SIIM this year will debut two new additions to the integrated learning program: "Vendor tie-in" sessions and the Shared learning community.

April 14, 2010 - Researchers found a new amyloid imaging agent for positron emission tomography (PET) to be efficacious in assigning patients with clinically probable Alzheimer's disease (AD) or amnestic mild cognitive impairment (MCI).

April 9, 2010 - The U.S. Food and Drug Administration (FDA) will no longer allow a third party review process on new radiotherapy equipment. The announcement came in a letter the FDA sent to 93 makers of radiation treatment devices, urging them to attend a workshop to address concerns about patient exposure to excess radiation from medical treatments and procedures.

April 7, 2010 - A dual-modality tomographic (DMT) breast scanner, developed by researchers at the University of Virginia Health System (UVA), in a pilot study pinpointed to a much finer degree than mammography, ultrasound, MRI and even a needle biopsy, the location of breast masses and more accurately distinguished between cancerous and harmless lesions.